Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Current Assets (2021 - 2025)

PAVmed (PAVM) has 5 years of Current Assets data on record, last reported at $4.2 million in Q3 2025.

  • For Q3 2025, Current Assets changed N/A year-over-year to $4.2 million; the TTM value through Sep 2025 reached $4.2 million, changed N/A, while the annual FY2024 figure was $2.2 million, 91.17% down from the prior year.
  • Current Assets reached $4.2 million in Q3 2025 per PAVM's latest filing, down from $5.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $82.6 million in Q4 2021 and bottomed at $2.2 million in Q4 2024.
  • Average Current Assets over 5 years is $37.8 million, with a median of $41.7 million recorded in 2021.
  • Peak YoY movement for Current Assets: skyrocketed 52.83% in 2022, then plummeted 91.17% in 2024.
  • A 5-year view of Current Assets shows it stood at $82.6 million in 2021, then crashed by 46.84% to $43.9 million in 2022, then crashed by 44.23% to $24.5 million in 2023, then tumbled by 91.17% to $2.2 million in 2024, then soared by 93.67% to $4.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $4.2 million in Q3 2025, $5.5 million in Q2 2025, and $3.6 million in Q1 2025.